Embolic Protection Device
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application PCT/US2007/024558, filed Nov 29, 2007. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,939,987 | Embolic Protection Device In force · High confidence | Emboline, Inc. | In force | High confidence | ||
| US 10,617,507 | Embolic Protection Device In force · High confidence | Emboline, Inc. | In force | High confidence | ||
| US 9,770,318 | Embolic Protection Device In force · Medium confidence | Emboline, Inc. | In force | Medium confidence | ||
| US 8,414,482 | Embolic Protection Device In force · High confidence | Emboline, Inc. | In force | High confidence | ||
| US 9,107,734 | Embolic Protection Device In force · High confidence | Emboline, Inc. | In force | High confidence | ||
| Application 17/167,699 | Embolic Protection Device Pending Not granted | Emboline, Inc. | Pending | Not granted | not computed |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Emboline, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.